Back to News
Market Impact: 0.2
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
Source: prnewswire.com
Legal & LitigationHealthcare & Biotech
Rosen Law Firm announced a securities class action lawsuit on behalf of Unicycive Therapeutics (NASDAQ: UNCY) investors who purchased shares between December 29, 2025 and June 29, 2026. The announcement creates legal and reputational risk for the biotech company, though the release provides no allegations, claimed damages, or financial impact details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
UNCY-0.85
More News
- Aker BP Q3 profit tops forecast on $870 million writedown reversal
- Kalshi, co-founders hit with criminal charges in US state of Utah
- Judge says Trump's bid to set aside California ballots would ‘wreak havoc’ on democracy
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- Utah criminally charges Kalshi with promoting illegal gambling
- FTC and 20 states sue Dollar General, saying it overcharged its poorest customers by millions